Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Falcinelli SD"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized mice.
    Autorzy:
    Ling L; International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    De C; International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Spagnuolo RA; International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Begum N; International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Falcinelli SD; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Archin NM; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Kovarova M; International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Silvestri G; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Wahl A; International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Margolis DM; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Garcia JV; International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2023 Dec 06; Vol. 19 (12), pp. e1011824. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    HIV Infections*
    HIV-1*
    Humans ; Mice ; Animals ; CD4-Positive T-Lymphocytes ; Virus Latency ; Virus Replication ; Anti-Retroviral Agents/pharmacology ; Anti-Retroviral Agents/therapeutic use ; RNA, Viral ; DNA ; Viral Load
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection.
    Autorzy:
    Gay CL; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    Kuruc JD; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    Falcinelli SD; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    Warren JA; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    Reifeis SA; Department of Biostatistics, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States.
    Kirchherr JL; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
    James KS; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
    Dewey MG; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
    Helms A; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    Allard B; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
    Stuelke E; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
    Gamble A; Argos Therapeutics, Durham, North Carolina, USA.
    Plachco A; Argos Therapeutics, Durham, North Carolina, USA.
    Gorelick RJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
    Eron JJ; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.; Department of Epidemiology, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States.
    Hudgens M; Department of Biostatistics, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States.
    Garrido C; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    Goonetilleke N; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    DeBenedette MA; Argos Therapeutics, Durham, North Carolina, USA.
    Tcherepanova IY; Argos Therapeutics, Durham, North Carolina, USA.
    Nicolette CA; Argos Therapeutics, Durham, North Carolina, USA.
    Archin NM; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
    Margolis DM; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States. .; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States. .; Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States. .; Department of Epidemiology, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Mar 20; Vol. 10 (1), pp. 5134. Date of Electronic Publication: 2020 Mar 20.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Dendritic Cells/*transplantation
    HIV Infections/*therapy
    HIV-1/*drug effects
    Histone Deacetylase Inhibitors/*therapeutic use
    Immunotherapy, Adoptive/*methods
    Vorinostat/*therapeutic use
    Adult ; CD4-Positive T-Lymphocytes/immunology ; Humans ; Immunologic Memory/immunology ; Male ; Middle Aged ; T-Lymphocytes, Cytotoxic/immunology ; Translational Research, Biomedical ; Treatment Outcome ; Vaccination
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Characterization of Host and Bacterial Contributions to Lung Barrier Dysfunction Following Co-infection with 2009 Pandemic Influenza and Methicillin Resistant Staphylococcus aureus .
    Autorzy:
    Nickol ME; Laboratory of Emerging and Re-Emerging Viruses, Department of Medical Microbiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada. .
    Ciric J; Laboratory of Emerging and Re-Emerging Viruses, Department of Medical Microbiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada. .
    Falcinelli SD; Department of Microbiology and Immunology, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. shane_falcinelli@med.unc.edu.
    Chertow DS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. .; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA. .
    Kindrachuk J; Laboratory of Emerging and Re-Emerging Viruses, Department of Medical Microbiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada. .
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2019 Jan 29; Vol. 11 (2). Date of Electronic Publication: 2019 Jan 29.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Alveolar Epithelial Cells/*microbiology
    Alveolar Epithelial Cells/*virology
    Blood-Air Barrier/*physiopathology
    Influenza, Human/*physiopathology
    Staphylococcal Infections/*physiopathology
    A549 Cells ; Coinfection/microbiology ; Coinfection/virology ; Humans ; Influenza A Virus, H1N1 Subtype ; Influenza, Human/microbiology ; Lung/pathology ; Methicillin-Resistant Staphylococcus aureus ; Protein Array Analysis ; Staphylococcal Infections/virology ; Virulence Factors ; Virus Replication
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies